The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results